selected scholarly activity
-
chapters
- Adjuvant Therapy for completely resected stage II Colon Cancer. Cochrane Database of Systematic Reviews.
-
conferences
- REAL-WORLD RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA. Journal of Urology. E863-E863. 2024
- Prostate cancer biomarker enrichment and treatment selection (PC-BETS) study: A Canadian cancer trials group phase II umbrella trial for metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 2020
- Prostate cancer biomarker enrichment and treatment selection (PC-BETS) study: A Canadian cancer trials group phase II umbrella trial for metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 5551-5551. 2020
- A multicenter phase II study of avelumab in patients with locally advanced or metastatic penile cancer (PC) who are unfit for, or have progressed on or after platinum-based chemotherapy: (ALPACA). Journal of Clinical Oncology. 2020
- Abstract P6-13-02: Subcutaneous trastuzumab for the treatment of HER2+ breast cancer in Canada: A cost-minimization study. Cancer Research. 2020
- Evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.. Journal of Clinical Oncology. e18548-e18548. 2018
- Abstract P5-20-17: Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. p5-20-17-p5-20-17. 2018
- Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. 2018
- Code status communication training in Canadian postgraduate oncology programs: A needs assessment survey.. Journal of Clinical Oncology. 13-13. 2017
- The PULSES project: Teaching the vital elements of code status discussions to oncology residents.. Journal of Clinical Oncology. 46-46. 2017
- Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.. Journal of Clinical Oncology. e12030-e12030. 2017
- The PULSES project: Teaching the vital elements of code status discussions to oncology residents.. Journal of Clinical Oncology. 10024-10024. 2017
- AN UNSUSPECTED CASE OF MYOCARDITIS ASSOCIATED WITH NIVOLUMAB USE. Journal of the American College of Cardiology. 2364-2364. 2017
- A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers. Annals of Oncology. 1116-1122. 2016
- A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Node Dissection on Axillary Surgery in Patients With Breast Cancer. Annals of Surgical Oncology. 164-164. 2016
- Bridging the gap: The design of a survivorship curriculum for interspecialty collaboration.. Journal of Clinical Oncology. 13-13. 2016
- Adenylate Cyclase Pathway And Progression Of Fibrosis. American Journal of Respiratory and Critical Care Medicine. 2016
- IND 205B: A phase II study of the PI3K inhibitor PX-866 and continued abiraterone/prednisone in patients with recurrent or metastatic castration resistant prostate cancer (CRPC) with PSA progression on abiraterone/prednisone.. Journal of Clinical Oncology. 279-279. 2015
- Changes in Practice Patterns for Completion Axillary Node Dissection in a Population-based Breast Cancer Cohort before and after the Dissemination of ACOSOC Z11 Results. Annals of Surgical Oncology. S69-S69. 2015
- Assessment of galectin-3, N-terminal pro-brain natriuretic peptide and inflammatory cytokines in patients with myocardial injury after initiation of adjuvant trastuzumab therapy. Clinical Biochemistry. 1144-1144. 2014
- Vitamin B12 (Vit B12) biochemical (BCH) deficiency (DEF) in non-diabetic breast cancer (BC) patients on NCIC CTG MA.32: A phase III randomized adjuvant BC trial comparing metformin (Met) to placebo (Pl).. Journal of Clinical Oncology. 542-542. 2014
- Increasing Utilization of Breast MRI: A Population Study. Annals of Surgical Oncology. 58-58. 2014
- Clinical-Pathologic Significance of Androgen Receptor (AR) Expression in Hormone Receptor (HR) Negative Breast Cancer. Modern Pathology. 48A-48A. 2014
- A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 5039-5039. 2013
- A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 2013
- Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC). Journal of Clinical Oncology. 2013
- 1440 EMERGENCE OF VARIANT HISTOLOGY DURING NEO-ADJUVANT CHEMO-THERAPY FOR MUSCLE INVASIVE URETHELIAL BLADDER CANCER IS COMMON AND ASSOCIATED WITH POOR PROGNOSIS. Investigative Urology. E590-E590. 2013
- 1441 INCIDENCE, CHARACTERISTICS, AND IMPLICATIONS OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING CISPLATIN BASED NEO-ADJUVANT CHEMOTHERAPY. Investigative Urology. E590-E591. 2013
- Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients. Cancer Research. A16-A16. 2012
- OT1-02-13: Cardiac Biomarkers on Trastuzumab (Cabot Trial): Determining the Cardiac Biomarker Profile in Breast Cancer Patients Receiving Adjuvant Trastuzumab Therapy.. Cancer Research. 2011
- Evaluation of second-line response to targeted therapy following progression on first-line cediranib, an oral pan-vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI), in advanced renal cell carcinoma (RCC).. Journal of Clinical Oncology. e15153-e15153. 2011
- Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC). Journal of Clinical Oncology. 2011
- A MULTI-INSTITUTIONAL PHASE II STUDY OF SINGLE AGENT ABI-007 IN PLATINUM REFRACTORY UROTHELIAL CARCINOMA. Annals of Oncology. 280-280. 2010
- A phase II study of single-agent nab-paclitaxel as second-line therapy in patients with metastatic urothelial carcinoma.. Journal of Clinical Oncology. TPS231-TPS231. 2010
- A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy.. Journal of Clinical Oncology. 595-595. 2010
- Accuracy of computerized tomography (CT) imaging in predicting pathologic stage for patients undergoing surgery for transitional cell carcinoma (TCC) of the bladder.. Journal of Clinical Oncology. e15111-e15111. 2010
- Preventing patupilone-induced diarrhea with high-dose corticosteroids.. Journal of Clinical Oncology. e13069-e13069. 2010
- A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma. Journal of Clinical Oncology. 2009
- The impact of preoperative breast magnetic resonance imaging (MRI) on surgical decision-making in young patients with breast cancer.. Cancer Research. 255S-255S. 2009
- Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium. Journal of Clinical Oncology. 5047-5047. 2008
- Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium. Journal of Clinical Oncology. 2008
- Meta-analysis examining the efficacy of serotonin and/or norepinephrine reuptake inhibitors in the treatment of women with hot flashes. Journal of Clinical Oncology. 20606-20606. 2008
- AZD2171 (Cediranib) is active in first line metastatic renal cell carcinoma (RCC): Interim results of a phase II trial. A trial of the PMH Phase II Consortium. Molecular Cancer Therapeutics. 3337S-3338S. 2007
- Causality assessment of adverse events in oncology clinical trials: A qualitative study. Pharmacoepidemiology and Drug Safety. S181-S181. 2007
- Development and validation of an adverse event causality assessment tool for use in oncology clinical trials. Pharmacoepidemiology and Drug Safety. S180-S181. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 2007
- A tool for assessing adverse events in phase I/II oncology clinical trials. Journal of Clinical Oncology. 2007
- Effects of adjuvant chemotherapy on the protein C anticoagulant pathway in patients with early stage breast cancer.. Journal of Clinical Oncology. 483S-483S. 2006
- Meta-analysis examining the efficacy of serotonin selective reuptake inhibitors in the treatment of women with hot flashes. Breast Cancer Research and Treatment. S269-S270. 2005
-
journal articles
- Effectiveness of physiotherapist-led tele-rehabilitation for older adults with chronic conditions: a systematic review and meta-analysis.. Disability and Rehabilitation. ahead-of-print:1-15. 2024
- Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 Pandemic.. Current Oncology. 31:5354-5366. 2024
- Factors Influencing the Decision of Individuals with Breast Cancer to Join an Exercise Oncology Trial. Journal of Cancer Education. 39:244-252. 2024
- MP53-03 REAL-WORLD RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA. Investigative Urology. 211:e863. 2024
- Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Current Oncology. 31:1803-1816. 2024
- Evaluating Wall-Mounted Prompts to Facilitate Physical Activity-Related Discussion between Individuals with Cancer and Oncology Health Care Providers: A Pre-post Survey Study. Physiotherapy Canada. Physiotherapie Canada. 76:34-45. 2024
- 2361MO Impact of positron emission tomography (PET) imaging on staging of muscle-invasive bladder cancer (MIBC) [PET-MUSE]. Annals of Oncology. 34:S1200-S1200. 2023
- Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab. Oncologist. 28:e712-e722. 2023
- Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer. CJC OPEN. 5:658-660. 2023
- Optimizing Cancer Survivorship Care: Examination of Factors Associated with Transition to Primary Care. Current Oncology. 30:2743-2750. 2023
- FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.. Journal of Clinical Oncology. 41:460-460. 2023
- Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study.. Journal of Clinical Oncology. 41:218-218. 2023
- The European Society of Cardiology Cardio-Oncology Guidelines. JACC: CardioOncology. 5:137-140. 2023
- Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). Journal of Clinical Oncology. 41:43-53. 2023
- A Survey-Based Study on Physical Activity Promotion for Individuals with a Current or Past Diagnosis of Cancer in Canada. Current Oncology. 29:9801-9812. 2022
- Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 25:453-462. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease. Acta Oncologica. 61:705-713. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.. Acta Oncologica. 61:705-713. 2022
- Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. Journal of the American Medical Association (JAMA). 327:1963-1963. 2022
- Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy. Investigative Urology. 207:1020-1028. 2022
- The Cardiologist's Role in the Management of Patients with a Genitourinary Cancer.. Israel Medical Association Journal. 24:175-178. 2022
- What Cardio-Oncology Lessons Can We Learn From Population-Based Data?. JACC: CardioOncology. 4:110-112. 2022
- BAYOU: A phase II, randomized, multicenter, double-blind, study of durvalumab (D) in combination with olaparib (O) for the first-line treatment of platinum-ineligible patients with unresectable, stage IV urothelial carcinoma (UC).. Journal of Clinical Oncology. 40:437-437. 2022
- Abstract GS1-08: CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438). Cancer Research. 82. 2022
- Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis. CJC OPEN. 3:1372-1382. 2021
- Ten ways to get a grip on designing and implementing a competency-based medical education training program. Canadian Medical Education Journal. 12:e81-e87. 2021
- The Hidden Curriculum in Postgraduate Medical Education: a Commentary. Journal of Cancer Education. 36:435-437. 2021
- 2020 Virtual International Conference on Residency Education. Canadian Medical Education Journal. 12:e120-e179. 2021
- Code Status Communication Training in Postgraduate Oncology Programs: A Needs Assessment. Current Oncology. 27:607-613. 2020
- Code Status Communication Training in Postgraduate Oncology Programs: A Needs Assessment.. Current Oncology. 27:607-613. 2020
- Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. The Lancet Oncology. 21:1574-1588. 2020
- Implementing Changes to a Residency Program Curriculum before Competency-Based Medical Education: A Survey of Canadian Medical Oncology Program Directors. Current Oncology. 27:614-620. 2020
- Implementing Changes to a Residency Program Curriculum before Competency-Based Medical Education: A Survey of Canadian Medical Oncology Program Directors.. Current Oncology. 27:614-620. 2020
- Strategies for Maintaining Educational Standards in Medical Oncology Residency Training in the Era of COVID-19: Experience from a Canadian Cancer Centre. Journal of Cancer Education. 35:1068-1069. 2020
- Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer. JAMA Oncology. 6:1751-1751. 2020
- Evaluation of a novel strategy to implement exercise evidence into clinical practice in breast cancer care: protocol for the NEXT-BRCA randomised controlled trial. BMJ Open Sport and Exercise Medicine. 6:e000922-e000922. 2020
- Improving Formative Assessments in Canadian Medical Oncology Residency Training. Current Oncology. 27:524-525. 2020
- Improving Formative Assessments in Canadian Medical Oncology Residency Training.. Current Oncology. 27:524-525. 2020
- Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada. Bladder Cancer. 6:363-392. 2020
- Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study. Investigative Urology. 203:1109-1116. 2020
- Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial. Journal of Hospital Infection. 105:280-288. 2020
- Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Journal of the Canadian Urological Association. 14:E154-E158. 2020
- Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer. Journal of the Canadian Urological Association. 14:123-130. 2020
- The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer.. npj Breast Cancer. 6:6. 2020
- A multicenter phase II study of avelumab in patients with locally advanced or metastatic penile cancer (PC) who are unfit for, or have progressed on or after platinum-based chemotherapy: (ALPACA).. Journal of Clinical Oncology. 38:TPS7-TPS7. 2020
- Effects of heat treatment on microstructure, mechanical and corrosion properties of 15-5 PH stainless steel parts built by selective laser melting process. Journal of Manufacturing Processes. 50:279-294. 2020
- Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases. Asian Journal of Andrology. 22:437-437. 2020
- The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer. npj Breast Cancer. 6:6. 2020
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. The Lancet. 394:2165-2172. 2019
- Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?. Oncologist. 24:1405-1409. 2019
- Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists. Breast Journal. 25:1222-1224. 2019
- Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma. Journal of the Canadian Urological Association. 13:318-327. 2019
- Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity. JACC: CardioOncology. 1:1-10. 2019
- A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy. Clinica Chimica Acta. 495:355-357. 2019
- An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction. Current Oncology. 26:240-246. 2019
- Longitudinal High-Sensitivity Cardiac Troponin I Measurements in Patients With Breast Cancer Receiving Trastuzumab. Canadian Journal of Cardiology. 35:545.e1-545.e2. 2019
- Surgical Attitudes toward Preoperative Breast Magnetic Resonance Imaging in Women with Early-Stage Breast Cancer. Current Oncology. 26:194-201. 2019
- Abstract PD6-04: Lifestyle intervention study (LISA) in early breast cancer (BC): An RCT of the effects of a telephone-based weight loss intervention (with educational materials) vs educational materials alone on disease-free survival (DFS). Cancer Research. 79:pd6-04-pd6-04. 2019
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area. Canadian Journal of Cardiology. 34:1059-1068. 2018
- Cctg BL12: Randomized phase II trial comparing nab-paclitaxel (Nab-P) to paclitaxel (P) in patients (pts) with advanced urothelial cancer progressing on or after a platinum containing regimen (NCT02033993).. Journal of Clinical Oncology. 36:4505-4505. 2018
- Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 13:e0209486-e0209486. 2018
- Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. Breast Cancer Research and Treatment. 164:371-378. 2017
- Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. The Lancet Oncology. 18:473-485. 2017
- A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer. Annals of Surgical Oncology. 23:3354-3364. 2016
- Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' views. Breast. 29:126-131. 2016
- Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer. Cancer immunology research. 4:881-892. 2016
- A Retrospective Study Evaluating the Impact of Preoperative Breast MRI on Surgical Decision-Making in Young Patients (≤50 Years) with Invasive Breast Cancer. Breast Cancer: Basic and Clinical Research. 10:BCBCR.S38432-BCBCR.S38432. 2016
- Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America. Prostate. 75:836-844. 2015
- Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate. Clinical Cancer Research. 21:1621-1627. 2015
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32. Journal of the National Cancer Institute. 107:djv006-djv006. 2015
- Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib. Journal of the Canadian Urological Association. 8:398-398. 2014
- A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients. Investigational New Drugs. 32:1005-1016. 2014
- Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy. Urologic Oncology: Seminars and Original Investigations. 32:975-980. 2014
- A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer. Investigational New Drugs. 32:746-752. 2014
- Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial. Journal of Clinical Oncology. 32:2231-2239. 2014
- Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel.. Journal of Clinical Oncology. 32:5051-5051. 2014
- Physician‐related facilitators and barriers to patient involvement in treatment decision making in early stage breast cancer: perspectives of physicians and patients. Health Expectations. 16:373-384. 2013
- A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium. Investigational New Drugs. 31:1008-1015. 2013
- Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study. The Lancet Oncology. 14:769-776. 2013
- Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).. Journal of Clinical Oncology. 31:1033-1033. 2013
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy. New England Journal of Medicine. 368:138-148. 2013
- Cardiac and Inflammation Biomarker Profile after Initiation of Adjuvant Trastuzumab Therapy. Clinical Chemistry. 59:327-329. 2013
- Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Journal of the Canadian Urological Association. 7:797-797. 2013
- Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Journal of the Canadian Urological Association. 7:44-44. 2013
- A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer. Investigational New Drugs. 30:1652-1659. 2012
- Phenytoin Toxicity in a Patient Receiving 5-Fluorouracil–Based Chemotherapy for Metastatic Colorectal Cancer. Current Oncology. 18:264-265. 2011
- Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus. Journal of Thrombosis and Haemostasis. 9:2313-2321. 2011
- Early stopping rules in oncology: Considerations for clinicians. European Journal of Cancer. 47:2381-2386. 2011
- A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium. Investigational New Drugs. 29:1045-1049. 2011
- A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials. Investigational New Drugs. 29:1013-1020. 2011
- Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c. Clinical Cancer Research. 17:5765-5773. 2011
- The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal‐based and cell‐based models. Journal of Thrombosis and Haemostasis. 9:767-775. 2011
- Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC).. Journal of Clinical Oncology. 29:241-241. 2011
- Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. Journal of the Canadian Urological Association. 4:50-50. 2010
- Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 37:88-97. 2010
- Is red meat intake a risk factor for breast cancer among premenopausal women?. Breast Cancer Research and Treatment. 117:1-8. 2009
- Endoscopic brachytherapy for obstructive colorectal cancer. Brachytherapy. 8:313-317. 2009
- A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma. Journal of Clinical Oncology. 27:e16058-e16058. 2009
- Adjuvant Therapy for completely resected Stage II Colon Cancer. Clinical Respiratory Journal. 2010:CD005390. 2008
- The need for additional safeguards in the informed consent process in schizophrenia research. Journal of Medical Ethics. 33:647-650. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 25:6508-6508. 2007
- A tool for assessing adverse events in phase I/II oncology clinical trials. Journal of Clinical Oncology. 25:6518-6518. 2007
- Hypoxia-Induced Lactate Dehydrogenase Expression and Tumor Angiogenesis. Clinical Colorectal Cancer. 6:442-446. 2007
- Effects of adjuvant chemotherapy on the protein C anticoagulant pathway in patients with early stage breast cancer. Journal of Clinical Oncology. 24:8563-8563. 2006
- Post-partum aortic dissection. Journal of Obstetrics and Gynaecology. 25:388-390. 2005
- Exploring the intersection of cancer, sepsis, and frailty: a scoping review. Discover Medicine. 1:56.
-
preprints